Monitoring Serum Calcium After Zoledronic Acid Infusion
Routine post-infusion monitoring of serum calcium is based on hypocalcemia risk.
- Post–first infusion: repeat serum calcium at 24 hours after infusion. [1]
- Additional calcium monitoring: measurement on day 2 and day 3 is optional and based on clinical status. [1]
Monitoring Serum 25-Hydroxy Vitamin D After Zoledronic Acid Infusion
Serum 25-hydroxy vitamin D is not routinely rechecked after zoledronic acid infusion in standard monitoring protocols.
- Vitamin D status is checked before infusion (for example, prior to each infusion in pediatric protocols). [1]
- Vitamin D supplementation is recommended around the time of zoledronic acid administration to reduce hypocalcemia risk. [2]
Clinical Timing Considerations for Hypocalcemia Risk
Late post-infusion decreases in calcium can occur, including decreases observed 9–11 days after administration in Paget disease trials. [2]
Practical Laboratory Plan
- Obtain serum calcium at 24 hours post-infusion after the first zoledronic acid infusion. [1]
- Add day-2 and day-3 calcium checks only when clinically indicated by risk factors or symptoms. [1]
- Reassess 25-hydroxy vitamin D prior to the next infusion rather than on a fixed post-infusion interval. [1]